The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease

被引:96
作者
Sampietro, M [1 ]
Caputo, L
Casatta, A
Meregalli, M
Pellagatti, A
Tagliabue, J
Annoni, G
Vergani, C
机构
[1] Univ Milan, Chair Gerontol & Geriat, Dept Internal Med, Milan, Italy
[2] IRCCS, Osp Maggiore Milano, Milan, Italy
关键词
Alzheimers disease; dementia; hemochromatosis; iron; APOE; mutation; disease onset;
D O I
10.1016/S0197-4580(01)00219-6
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
NEUROBIOL AGING. In the present study we analysed the genotype of HFE, the gene involved in hemochromatosis, in 107 patients with sporadic late-onset AD and in 99 age-matched non-demented controls. We observed that patients carrying the mutant HFE-H63D allele had a mean age at onset of 71.7 +/- 6.0 years versus 76.6 +/- 5.8 years of those who were homozygous for the wild-type allele (p = 0.001). The frequency of the HFE-H63D mutation was highest (0.22) in the patients aged < 70 years at the time of disease onset, whereas it was 0.12 in those with disease onset at an age of 70-80 years, and 0.04 in those aged more than 80 years, The APOE genotype did not significantly modify the effect of HFE on age at onset. We conclude that mild disturbances of iron homeostasis associated with a common genetic determinant may interact with other pathogenic mechanisms involved in AD. HFE mutations may anticipate AD clinical presentation in susceptible individuals. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:563 / 568
页数:6
相关论文
共 40 条
[1]  
Ballerini C, 1999, ANN NEUROL, V45, P397, DOI 10.1002/1531-8249(199903)45:3<397::AID-ANA18>3.0.CO
[2]  
2-4
[3]   Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis [J].
Bastin, JM ;
Jones, M ;
O'Callaghan, CA ;
Schimanski, L ;
Mason, DY ;
Townsend, ARM .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) :931-941
[4]   ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative [J].
Blacker, D ;
Haines, JL ;
Rodes, L ;
Terwedow, H ;
Go, RCP ;
Harrell, LE ;
Perry, RT ;
Bassett, SS ;
Chase, G ;
Meyers, D ;
Albert, MS ;
Tanzi, R .
NEUROLOGY, 1997, 48 (01) :139-147
[5]   APOLIPOPROTEIN-E ASSOCIATED WITH ASTROCYTIC GLIA OF THE CENTRAL NERVOUS-SYSTEM AND WITH NONMYELINATING GLIA OF THE PERIPHERAL NERVOUS-SYSTEM [J].
BOYLES, JK ;
PITAS, RE ;
WILSON, E ;
MAHLEY, RW ;
TAYLOR, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (04) :1501-1513
[6]   Clinical and biochemical abnormalities in people heterozygous for hemochromatosis [J].
Bulaj, ZJ ;
Griffen, LM ;
Jorde, LB ;
Edwards, CQ ;
Kushner, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24) :1799-1805
[7]   RAPID INDUCTION OF ALZHEIMER A-BETA AMYLOID FORMATION BY ZINC [J].
BUSH, AI ;
PETTINGELL, WH ;
MULTHAUP, G ;
PARADIS, MD ;
VONSATTEL, JP ;
GUSELLA, JF ;
BEYREUTHER, K ;
MASTERS, CL ;
TANZI, RE .
SCIENCE, 1994, 265 (5177) :1464-1467
[8]  
Carella M, 1997, AM J HUM GENET, V60, P828
[9]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[10]  
Fairbanks VF, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P42